APA (7th ed.) Citation

S, J., X, Q., MA, H., TL, O., I, Z., R, P., . . . CE, C. (2025). Exploiting Metabolic Vulnerabilities in Cancer with a Dual-Transporter-Targeted 2-Deoxyglucose Analogue for Low-Dose, Potent Antitumor Activity. Journal of the American Chemical Society, 147(47), 43267. https://doi.org/10.1021/jacs.5c18136

Chicago Style (17th ed.) Citation

S, Jeon, Qin X, Hildebrand MA, Odom TL, Zamborini I, Patel R, Liu X, Seo C, and Callmann CE. "Exploiting Metabolic Vulnerabilities in Cancer with a Dual-Transporter-Targeted 2-Deoxyglucose Analogue for Low-Dose, Potent Antitumor Activity." Journal of the American Chemical Society 147, no. 47 (2025): 43267. https://doi.org/10.1021/jacs.5c18136.

MLA (9th ed.) Citation

S, Jeon, et al. "Exploiting Metabolic Vulnerabilities in Cancer with a Dual-Transporter-Targeted 2-Deoxyglucose Analogue for Low-Dose, Potent Antitumor Activity." Journal of the American Chemical Society, vol. 147, no. 47, 2025, p. 43267, https://doi.org/10.1021/jacs.5c18136.